Disease surveillance is an insurance policy staffed by people: epidemiologists, laboratory teams and data specialists. The fight over a $112 million contract shows what happens when the premium stops being paid.
For insurers, lenders and investors, Central Asia's digital sovereignty drive is a risk story: concentrated dependence on a foreign platform met a war, and governments are now rewriting the rules.